Blog
RSS FeedPosted by Michael Wonder on 23 Jan 2023
China’s drug pricing policy impedes biotech profits
23 January 2023 - Beijing’s push to boost the sector has been undermined by reimbursement rules. ...
Posted by Michael Wonder on 11 Jan 2023
Prescription drug policy, 2022 and 2023: the year in review and the year ahead
9 January 2023 - This past year featured many significant developments in the prescription drug policy area, most notably the passage ...
Posted by Michael Wonder on 21 Dec 2022
Ontario expanding safe use of biosimilars
20 December 2022 - Transitioning to biosimilars will allow province to invest in and improve access to medicines. ...
Posted by Michael Wonder on 20 Dec 2022
A National Medicines Policy fit for the future
20 December 2022 - An updated and strengthened National Medicines Policy has been delivered to the Australian Government. ...
Posted by Michael Wonder on 20 Dec 2022
Just released National Medicines Policy sets high ambitions for better health outcomes for all Australians
20 December 2022 - Medicines Australia congratulates the Government on the release of the much anticipated National Medicines Policy, after ...
Posted by Michael Wonder on 20 Dec 2022
Refreshed National Medicines Policy
20 December 2022 - The Australian Government has released an updated and strengthened National Medicines Policy. ...
Posted by Michael Wonder on 24 Oct 2022
Saskatchewan becomes sixth Canadian province to implement a biosimilar switching policy
21 October 2022 - Saskatchewan joined five provinces and one territory in implementing a biosimilar switching policy, allowing for reference ...
Posted by Michael Wonder on 17 Oct 2022
Medicare reports
17 October 2022 - Minister for Health and Aged Care, Mark Butler has issued the following statement regarding Medicare reporting. ...
Posted by Michael Wonder on 26 Sep 2022
National Medicines Policy draft strides ahead but still room for improvement
26 September 2022 - Stakeholders have until tomorrow night to submit their feedback on the refreshed National Medicines Policy that ...
Posted by Michael Wonder on 11 Sep 2022
Health movement in South Korea fights for universal access to medicines
10 September 2022 - Civil society in South Korea renewed its commitment to ensure universal access to medicines and public pharmaceutical ...
Posted by Michael Wonder on 05 Sep 2022
New PM will ‘inherit an NHS in its most challenging state for decades’
5 September 2022 - Warning comes from NHS leaders as new Prime Minister prepares to move into Number 10. ...
Posted by Michael Wonder on 03 Sep 2022
Every life is worth the same, but maybe not at PHARMAC
4 September 2022 - One of the dubious consequences of our obsession with race is the collection of data on ...
Posted by Michael Wonder on 29 Aug 2022
Amazon versus Apple: only one will rewrite the rules of health care
29 August 2022 - Big tech has had a surprisingly small impact on U.S. healthcare, so far. ...
Posted by Michael Wonder on 22 Aug 2022
To improve access and equity, move vaccine coverage to Medicare Part B
17 August 2022 - Within the Inflation Reduction Act of 2022 is a provision worthy of praise: the elimination of cost-sharing ...
Posted by Michael Wonder on 22 Aug 2022
National Medicines Policy review – registrations for targeted stakeholder consultation sessions and open public forum
22 August 2022 - The Department of Health and Aged Care is inviting stakeholders to provide feedback on the revised ...